JOJinyoung Oh

Jinyoung Oh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jinyoung Oh has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Younghoon Jeon

    Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea

    5 shared publications
  • Sung Hye Byun

    Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu 41404, Republic of Korea

    4 shared publications
  • Kyung-Hwa Kwak

    Department of Anesthesiology and Pain Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu 41944, Republic of Korea

    3 shared publications
  • Daehyun Jo

    Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Korea

    2 shared publications
  • Dong Gun Lim

    Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Daegu, Korea

    2 shared publications
  • Eunsoo Kim

    Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Busan, Korea

    2 shared publications

Latest Publications

  • Open Access

    Stellate ganglion block associated with changes in depression and anxiety in idiopathic sudden sensorineural hearing loss: A retrospective observational study

    by Jinyoung Oh, Sungsik Park, Kyung Hwa Kwak, Dong Gun Lim, Seung Wook Hong, Younghoon Jeon

    Idiopathic sudden sensorineural hearing loss (ISSNHL) is often accompanied by depression and anxiety. Stellate ganglion block (SGB) is useful to treat ISSNHL by enhancing cochlear perfusion. Recently, SGB has been reported to improve depressive symptoms in posttraumatic stress disorder, but it remains unclear whether SGB can decrease depressive symptoms and anxiety in patients with ISSNHL. In this single-center retrospective observational study, 35 patients with ISSNHL were included. Patients were treated with dexamethasone, low-molecular-weight dextran, and SGB. Depressive and anxiety symptoms were assessed using the Beck depression inventory (BDI) and generalized anxiety disorder-7 (GAD-7) before treatment (baseline), 1 hour after the 1st SGB (1 H) and 30 days after treatment (30D). Auditory function was evaluated by pure-tone audiometry (PTA) before and 30 days after treatment. PTA threshold significantly improved at 30D (47.9 ± 27.7), compared to baseline (68.0 ± 23.2) ( P < .001). The BDI significantly decreased at 1 H (5.5 ± 8.0) and 30D (4.5 ± 7.4), compared to baseline (9.1 ± 8.2) ( P < .0001). The GAD-7 significantly decreased at 1 H (2.3 ± 3.0) and Day 30 (1.9 ± 2.6), compared to baseline (4.7 ± 3.6) ( P < .0001). However, improvement in PTA is not correlated with improvement in BDI or GAD-7. SGB was associated with significant decreases in depressive and anxiety symptoms in patients with ISSNHL, which were not correlated with hearing recovery. These findings suggest that SGB may provide a potential benefit for mood improvement, independent of its effect on hearing recovery in this population.


  • Open Access

    Updated pediatric cardiopulmonary resuscitation: a comprehensive review of the 2025 guidelines

    by Jeong Eun Lee, Mihui Kim, Eun Kyung Choi, Jiyong Yeom, Jinyoung Oh, Sung-Hye Byun, Dong Gun Lim, Hoon Jung

    Pediatric cardiac arrest differs fundamentally from adult arrest in its etiology, physiology, and clinical course. In children, most events arise from progressive respiratory failure or circulatory compromise rather than primary cardiac causes. The 2025 American Heart Association pediatric cardiopulmonary resuscitation (CPR) guidelines provide an updated, evidence-based framework that reflects these distinctions. This review summarizes key revisions across basic life support, advanced life support, and post-cardiac arrest care (PCAC), and outlines practical considerations for clinical implementation. Major updates include refined chest compression techniques for infants, earlier administration of epinephrine for non-shockable rhythms, revised management of foreign-body airway obstruction, and clearer guidance on the use and limitations of end-tidal carbon dioxide monitoring. The guidelines also emphasize targeted hemodynamic management, including maintaining diastolic pressures ≥ 25 mmHg in infants and ≥ 30 mmHg in children during CPR, and sustaining systolic and mean arterial pressures above the age-specific 10th percentile after return of spontaneous circulation. Temperature management prioritizes the strict avoidance of hyperthermia, with the optional use of structured temperature control protocols. The unified Chain of Survival—comprising (1) recognition and emergency activation, (2) high-quality CPR, (3) defibrillation, (4) advanced resuscitation, (5) PCAC, and (6) recovery and survivorship—serves as an integrated framework linking early recognition of arrest to long-term rehabilitation. Implementation of these recommendations requires coordinated teamwork, system-level preparedness, and age-appropriate clinical decision-making. Applied within this framework, the 2025 pediatric CPR guidelines have the potential to improve survival and neurological outcomes in infants and children experiencing cardiac arrest.

  • Open Access

    Clinical practice guidelines for the management of refractory postherpetic neuralgia by the Korean Pain Society

    by Hee Yong Kang, Chung Hun Lee, Doo-Hwan Kim, Yeon-Dong Kim, Won-Joong Kim, Eunsoo Kim, Jae Hun Kim, Hyun Jung Kim, Yangki Minn, Kyungseung Yang, et al.

    Hee Yong Kang, Chung Hun Lee, Doo-Hwan Kim, Yeon-Dong Kim, Won-Joong Kim, Eunsoo Kim, Jae Hun Kim, Hyun Jung Kim, Yangki Minn, Kyungseung Yang, Jinyoung Oh, Yongjae Yoo, So Young Lim, Mihn-Sook Jue, Eun Joo Choi, Kunhee Han, and Seong-Soo Choi. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25161


  • Open Access

    Polydeoxyribonucleotide (PDRN) Selectively Promotes Osteoblast Differentiation Without Affecting Osteoclastogenesis

    by Younghoon Jeon, Eunjung Heo, Xian Jin, Dong-Kyo Lee, Xiangguo Che, Hyun-Ju Kim, Sung-Hye Byun, Je-Yong Choi, Jeongkyu Choi, Jinyoung Oh

    Developing novel anabolic agents for bone regeneration remains a clinical priority. Polydeoxyribonucleotide (PDRN) exhibits tissue-regenerative properties, but its direct cellular effects on bone remodeling remain unclear. This in vitro study investigated PDRN’s effects on osteoblast (MC3T3-E1) and osteoclast (primary bone marrow-derived macrophages) differentiation. We evaluated metabolic activity, gene/protein expression, and specific differentiation markers using MTS, qRT-PCR, Western blotting, and functional assays (ALP, Alizarin Red S, TRAP, pit formation). In osteoblasts, PDRN dose-dependently modulated metabolic activity while upregulating the early transcription factor Runx2. PDRN significantly enhanced osteoblast differentiation, evidenced by increased ALP activity, elevated mineralized matrix deposition, and robust upregulation of osteocalcin and Runx2. Conversely, PDRN exhibited no direct effect on osteoclast precursor metabolic activity, differentiation, or resorptive function. These findings support a working hypothesis in which PDRN selectively promotes osteoblast differentiation without directly affecting osteoclastogenesis. While further pharmacological investigations are required to definitively elucidate the specific purinergic receptor mechanisms, our results highlight PDRN as a promising candidate anabolic agent for bone regeneration.


  • Open Access

    The Role of Follistatin-like 1 in the Cross-Talk Among Osteoclastogenesis, Bone Marrow Stromal Cell Migration, and Osteoblastogenesis In Vitro

    by Yongxu Piao, Xiangguo Che, Xian Jin, Dong-Kyo Lee, Min Park, Eun-Jung Heo, Jinyoung Oh, Seong-Gon Kim, Dae-Chul Cho, Hyun-Ju Kim, et al.

    Background: Bone remodeling depends on the dynamic balance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation. Follistatin-like 1 (FSTL1) has been reported as an osteoclast-secreted protein that inhibits osteoclast differentiation, but its direct effects on osteoblast differentiation remain unclear. This study aimed to determine whether FSTL1 regulates osteoblast differentiation and mesenchymal stem cell migration and characterizes its role in osteoclast-osteoblast cellular cross-talk under in vitro conditions. Methods: Bone marrow-derived macrophages (BMMs) and stromal cells (BMSCs) from mice were used to induce osteoclast and osteoblast differentiation, respectively. Chemotaxis was assessed by Transwell migration, and osteoblast differentiation was evaluated in BMSC and MC3T3-E1 cells using staining, qRT-PCR, Western blotting, and proliferation assays. Results: FSTL1 significantly suppressed osteoclast differentiation and resorptive activity, confirmed by TRAP staining and pit assay, respectively. Expression of osteoclast markers such as NFATc1, TRAP, and DC-STAMP was reduced under FSTL1 treatment. In BMSCs, FSTL1 did not affect proliferation but significantly enhanced chemotaxis. Moreover, FSTL1 promoted osteogenic differentiation and mineralization, as demonstrated by increased ALP activity and Alizarin Red S staining. In MC3T3-E1 pre-osteoblasts, FSTL1 increased cell proliferation and mineralization by MTS and Alizarin Red staining. Key osteogenic markers, including Runx2 and osteocalcin, were also upregulated. Conclusions: Osteoclast-derived FSTL1 significantly suppresses osteoclastogenesis and promotes mesenchymal cell chemotaxis and osteogenic differentiation, indicating a role in regulating osteoclast–osteoblast cellular interactions in vitro. Targeting FSTL1 signaling may represent a promising therapeutic strategy for osteoporosis and other disorders of impaired bone remodeling.


  • Open Access

    Successful awake video-laryngoscopic intubation in a patient with a giant mobile vocal process granuloma causing dynamic glottic obstruction: A case report

    by Jinyoung Oh, Sou-Hyun Lee, Kyung-Hwa Kwak, Younghoon Jeon, Jongone Park, Sung-Hye Byun

    Rationale: Vocal process granulomas are benign laryngeal lesions that are often asymptomatic but can cause critical airway obstruction upon rapid enlargement, although rare. In such cases, conventional induction of general anesthesia may lead to complete airway collapse. Therefore, careful selection of the anesthesia induction technique used is crucial to ensure patient safety, with awake intubation typically being preferred. Patient concerns: A 64-year-old woman presented to the emergency department with progressive dyspnea and stridor over 3 days. She had a history of hoarseness following phacoemulsification under general anesthesia with endotracheal intubation. Diagnoses: Follow-up laryngoscopy revealed a giant, stalked granuloma attached to the posterior one-third of the left vocal cord, nearly obstructing the glottic opening. Preinduction fiberoptic bronchoscopy (FOB) confirmed near-complete dynamic glottic obstruction during inspiration. Interventions: Emergency laryngeal microscopic surgery was planned. Due to the high risk of airway compromise during induction, awake video laryngoscope (VL)-guided intubation was selected over FOB-guided intubation, as the latter was limited by its inability to provide simultaneous visualization of the lesion, glottis, and endotracheal tube, as well as by insufficient mechanical support. Airway preparation included topical lidocaine, superior laryngeal nerve block, and transtracheal block. Remifentanil infusion and high-flow nasal oxygen were used to optimize patient comfort and oxygenation. An endotracheal tube with an internal diameter of 5.5 mm was successfully advanced during exhalation using the VL-guided approach. Outcomes: The surgery was completed without complications. At the 2-week, 2-month, and 1-year follow-ups, the patient remained asymptomatic, and laryngoscopy showed a well-healed surgical site. Lessons: Awake VL-guided intubation can be a safe and effective alternative to FOB for managing critical airways caused by giant, mobile vocal process granulomas. This technique offers continuous visualization, facilitates safer tube advancement, and reduces the risk of trauma and highlights the importance of integrating multidisciplinary collaboration and meticulous preinduction planning to optimize airway management.

  • Open Access

    A Comparative Study of Endoscopic versus Percutaneous Epidural Neuroplasty in Lower Back Pain: Outcomes at Six-Month Follow Up

    by Jong Bum Choi, Jae Chul Koh, Daehyun Jo, Jae Hyung Kim, Won Sok Chang, Kang Taek Lim, Hyung Gon Lee, Ho Sik Moon, Eunsoo Kim, Sun Yeul Lee, et al.

    Background and Objectives: Endoscopic epidural neuroplasty (EEN) facilitates adhesiolysis through direct epiduroscopic visualization, offering more precise neural decompression than that exhibited by percutaneous epidural neuroplasty (PEN). We aimed to compare the effects of EEN and PEN for 6 months after treatment with lower back and radicular pain in patients. Methods: This retrospective study compared the visual analog scale (VAS) and Oswestry disability index (ODI) scores in patients with low back and radicular pain who underwent EEN or PEN with a steering catheter. The medical records of 107 patients were analyzed, with 73 and 34 undergoing EEN and PEN, respectively. Results: The VAS and ODI scores decreased at all time points after EEN and PEN. VAS and ODI scores decreased more in the EEN group than those in the PEN group at 1 day and 1- and 6-months post-procedure, indicating superior pain relief for both lower back and radicular pain through EEN. Conclusions: EEN is a superior treatment of pain control than PEN in lower back and radicular pain patients.


  • Open Access

    Trends in the prescription of opioids and gabapentinoids in patients with failed back surgery syndrome in Korea: a population-based study

    by Jinyoung Oh, Jinseok Yeo

    Jinyoung Oh and Jinseok Yeo. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.23246


  • Open Access

    Analgesic effects of combined transversus abdominis plane block and intramuscular electrical stimulation in patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a randomized controlled trial

    by Hyun-Chang Kim, Jinyoung Park, Jinyoung Oh, Minjae Kim, Eun Jung Park, Seung Hyuk Baik, Young Song

    Background: To evaluate the analgesic efficacy of a four-quadrant transversus abdominis plane (4QTAP) block and a combination of 4QTAP block with needle electrical twitch and intramuscular electrical stimulation (NETOIMS) in patients undergoing cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Materials and Methods: Eighty-one patients who underwent CRS followed by HIPEC were included in this study. Patients were randomly assigned to one of three groups: group 1 (intravenous patient-controlled analgesia, control group), group 2 (preoperative 4QTAP block), and group 3 (preoperative 4QTAP block and postoperative NETOIMS). The primary study endpoint was the pain score assessed by the visual analog scale (VAS: 0, no pain; 10, worst imaginable pain) on postoperative day (POD) 1. Results: The VAS pain score on POD 1 was significantly lower in group 2 than in group 1 (6.0±1.7 and 7.6±1.9, P=0.004), whereas that in group 3 was significantly lower than that in groups 1 and 2 (PP=0.004, respectively). Opioid consumption and nausea and vomiting incidence during POD 7 were significantly lower in group 3 than in groups 1 and 2. Gait speed and peak cough flow on POD 4 and 7, as well as the quality of recovery (QoR)-40 score on POD 4, were significantly higher in group 3 than in groups 1 and 2. Conclusions: The combination of a 4QTAP block with NETOIMS provided more effective analgesia than a 4QTAP block alone after CRS, followed by HIPEC, and enhanced functional restoration and quality of recovery.


  • Open Access

    Effect of Minimum Bronchial Cuff Volume of Left-Sided Double-Lumen Tube for One-Lung Ventilation on the Change in Bronchial Cuff Pressure during Lateral Positioning in Thoracic Surgery: A Prospective Observational Study

    by Young-Woo Do, Jong-Hae Kim, Kyungmin Kim, Jinyoung Oh, Kyung-Hwa Kwak, Younghoon Jeon, Sung-Hye Byun

    The minimum bronchial cuff volume (BCVmin) of a double-lumen tube (DLT) without air leaks during lung isolation may vary among individuals, and lateral positioning could increase the bronchial cuff pressure (BCP). We investigated the effect of initially established BCVmin (BCVi) on the change in BCP by lateral positioning. Seventy patients who underwent elective lung surgery were recruited and divided into two groups according to the BCVi obtained during anesthetic induction in each patient. Outcome analysis was conducted using data from 39 patients with a BCVi greater than 0 (BCVi > 0 group) and 27 with a BCVi of 0 (BCVi = 0 group). The primary outcome was a change in the value measured in the supine and lateral positions of the initially established BCP (BCPi; BCP at the time of BCVi injection), which was significantly larger in the BCVi > 0 group than in the BCVi = 0 group (1.5 (0.5–6.0) cmH2O vs. 0.0 (0.0–1.0) cmH2O; p < 0.001). BCVi was related to the left main bronchus (LMB) diameter (Spearman’s rho = 0.676, p < 0.001) and the gap between the LMB diameter and the outer diameter of the bronchial cuff (Spearman’s rho = 0.553, p < 0.001). Therefore, selecting a DLT size with a bronchial cuff that fits each patient’s LMB may be useful in minimizing the change in BCP when performing lateral positioning during thoracic surgery. If the bronchial cuff requires unavoidable initial inflation, it is necessary to be aware that BCP may increase during lateral positioning and to monitor the BCP regularly if possible.